News: Press Release
TissueTech, Inc. Names Adrian Roji Chief Commercial Officer
New Chief Commercial Officer brings broad experience in regenerative medicine MIAMI – March 6, 2018 – TissueTech Inc. announced today it has named Adrian Roji Chief Commercial Officer to lead the company’s aggressive commercial expansion in the rapidly growing amniotic… read more
AMNIOX Medical Awarded Premier Agreement for Regenerative Medicine Products
Offers Access to Amniotic Membrane Products to Premier Members ATLANTA, GA – December 11, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, has been awarded a group purchasing agreement for Regenerative Skin Grafting Products with Premier. Effective January… read more
Bio-Tissue Announces First Study to Demonstrate Corneal Nerve Regeneration in Patients with Dry Eye Disease with the Use of PROKERA
Company’s Proprietary Cryopreserved Amniotic Membrane Continues to Advance Treatment of the Ocular Surface MIAMI, November 9, 2017 – Bio-Tissue, Inc., a business unit of TissueTech, Inc., announced today the publication of “Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in… read more
AMNIOX Medical Introduces RESPINA™ at NASS 2017
RESPINA umbilical cord/amniotic membrane matrix for microdiscectomy earns 2017 Spine Technology Award ORLANDO – October 26, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the introduction of RESPINA its cryopreserved umbilical cord/amniotic membrane matrix at the North American Spine… read more
TissueTech Inc. Awarded Four Patents for Proprietary Technology to Use Placental Tissue for Regenerative Medicine
Company has more than 40 issued patents MIAMI – September 14, 2017 – TissueTech Inc. announced today that it has been awarded four patents by the U.S. Patent Trademark Office. Two of the patents cover methods of promoting bone formation… read more
TissueTech, Inc. Names John Arnott, Industry Executive, to Board of Directors
Arnott brings experience in a wide range of global healthcare businesses MIAMI – August 3, 2017 – TissueTech Inc. announced today that it has named John Arnott to its Board of Directors. Mr. Arnott was most recently Operating Partner and… read more
TissueTech, Inc. Names Dr. Herbert B. Slade as Chief Medical Officer
MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary… read more
Study Demonstrating Improved Outcomes in Pain Reduction and Function for Discectomy Patients with CLARIX® 100 Highlighted in Medical Journal
Proprietary technology demonstrates significant improvement in short-term and long-term outcomes. ATLANTA – July 10, 2017 – AMNIOX Medical, Inc., a TissueTechTM, Inc. company, announced today that the results of a clinical study on the efficacy of CLARIX Cryopreserved Amniotic Membrane in… read more
Amniox Medical Enters into Agreement with Intalere
ATLANTA, GA – June 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company has announced an agreement with Intalere, to serve their members with its market leading human tissue allograft technology composed of both umbilical cord and amniotic membrane… read more
New Clinical Evidence Continues to Support the Effectiveness and Value of AMNIOX Medical Product
Nine Posters Demonstrating the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC ATLANTA, GA – May 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today that nine clinical posters demonstrating the effectiveness of NEOX® Wound… read more